NCT02145871View on ClinicalTrials.gov

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

PHASE3CompletedINTERVENTIONAL

Enrollment

282

Participants

Timeline

Start Date

May 21, 2014

Primary Completion Date

March 14, 2024

Study Completion Date

March 14, 2024

Conditions

Bladder Cancer

Interventions

OTHER

standard fluid management

OTHER

fluid management guided by the EV1000

Trial Locations (5)

10021

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11725

Memorial Sloan Kettering Cancer Center @ Commack, Commack

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02145871 - A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy | Biotech Hunter | Biotech Hunter